Table 6.
Groups | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Observation group (n=37) | 57.37±6.21 | 65.89±6.64* | 28.45±4.21 | 33.66±5.47* | 24.39±2.47 | 24.84±2.22 | 1.14±0.31 | 1.28±0.27* |
Control group (n=33) | 57.84±5.82 | 63.13±7.21* | 28.77±4.72 | 33.13±5.16* | 24.41±2.38 | 24.06±2.24 | 1.12±0.28 | 1.26±0.24* |
t value | 0.336 | 1.618 | 0.036 | 0.405 | 0.972 | 1.461 | 0.291 | 0.318 |
P | 0.738 | 0.111 | 0.972 | 0.687 | 0.816 | 0.149 | 0.772 | 0.752 |
Note: compared with before treatment;
P<0.05.